This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Oracle (ORCL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Oracle (ORCL) give a sense of how the business performed in the quarter ended August 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Dow Up 3 Straight Sessions, Nasdaq Leads on Tesla Upgrade
by Mark Vickery
Tesla's potential half-trillion-dollar gain in market value on the company's Dojo supercomputer is leading the stock higher +10% on the day.
Why Investors Should Focus on High-Quality Stocks & ETFs
by Neena Mishra
We discuss the macroeconomic outlook & buying opportunities.
Oracle (ORCL) Q1 Earnings Top Estimates
by Zacks Equity Research
Oracle (ORCL) delivered earnings and revenue surprises of 4.39% and 0%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Market Eagerly Awaits Inflation Numbers
by Zacks Equity Research
Market Eagerly Awaits Inflation Numbers.
Gearing Up for a Busy Trading Week
by Mark Vickery
Mid-week, we'll see new CPI and PPI data. These will be the last of the big economic prints reporting ahead of next week's Fed meeting.
Is Oracle (ORCL) A Buy Ahead of Fiscal Q1 Earnings Announcement?
by Bryan Hayes
The bullish artificial intelligence theme has helped propel ORCL stock more than 50% this year.
Oracle (ORCL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Oracle's (ORCL) fiscal first-quarter 2024 performance is expected to have benefited from the continued momentum in its cloud infrastructure services.
Descartes Systems (DSGX) Q2 Earnings Lag Estimates
by Zacks Equity Research
Descartes Systems (DSGX) delivered earnings and revenue surprises of -3.03% and 3.46%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
Oracle (ORCL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed the most recent trading day at $124.33, moving +0.28% from the previous trading session.
Software Stocks & ETFs: The Next Big AI Opportunity?
by Neena Mishra
Software stocks could be big beneficiaries of increased AI adoption
The Zacks Analyst Blog Highlights Oracle, Abbott Laboratories, Sanofi, Realty Income and Hilton Worldwide Holdings
by Zacks Equity Research
Oracle, Abbott Laboratories, Sanofi, Realty Income and Hilton Worldwide Holdings are part of the Zacks top Analyst Blog.
Top Stock Reports for Oracle, Abbott & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 15 major stocks, including Oracle Corporation (ORCL), Abbott Laboratories (ABT) and Sanofi (SNY).
Investors Heavily Search Oracle Corporation (ORCL): Here is What You Need to Know
by Zacks Equity Research
Oracle (ORCL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Canaan (CAN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Canaan (CAN) delivered earnings and revenue surprises of -286.67% and 10.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed at $116.84 in the latest trading session, marking a +0.67% move from the prior day.
Oracle (ORCL) Enables Royal Flying Doctor Service's Record
by Zacks Equity Research
Oracle (ORCL) enables the Royal Flying Doctor Service to unveil a fresh digital health record solution, leveraging the capabilities of Oracle Autonomous Database.
Oracle (ORCL) Helps MosaicML to Accelerate AI Model Training
by Zacks Equity Research
Oracle (ORCL) announces that it has been selected by MosaicML as the preferred cloud infrastructure partner to accelerate AI model training.
2 Stocks With Bullish "Shakeout" Patterns
by Andrew Rocco
During a shakeout, weaker and more speculative investors tend to panic and sell their holdings. However, Strategist Andrew Rocco explains why this process can clear out the market of these unstable participants, leaving behind a more resilient investor base.
Oracle (ORCL) Collaborates With White House CancerX Project
by Zacks Equity Research
Oracle (ORCL) partners with the White House CancerX Initiative as a founding member to contribute to the battle against cancer.
Oracle (ORCL) Stock Moves -0.04%: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed at $116.54 in the latest trading session, marking a -0.04% move from the prior day.
Here is What to Know Beyond Why Oracle Corporation (ORCL) is a Trending Stock
by Zacks Equity Research
Oracle (ORCL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for USMV
Oracle (ORCL) Achieves Authorization for Top-Secret Cloud Data
by Zacks Equity Research
Oracle (ORCL) Cloud Infrastructure receives authorization to host classified TS/SCI missions by the U.S. Intelligence Community.
Zacks Investment Ideas feature highlights: Microsoft, Netflix, Nvidia, Ionq and Oracle
by Zacks Equity Research
Microsoft, Netflix, Nvidia, Ionq and Oracle have been highlighted in this Investment Ideas article.